Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay

The 2013 update of the American Society of Clinical Oncology-College of American Pathologists (ASCO-CAP) human epidermal growth factor receptor 2 (HER2) testing guidelines recommend using an alternative chromosome 17 probe assay to resolve HER2 results determined to be equivocal by immunohistochemis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res
Autors principals: Desai, Neelam V., Torous, Vanda, Parker, Joel, Auman, James T., Rosson, Gary B., Cruz, Cassandra, Perou, Charles M., Schnitt, Stuart J., Tung, Nadine
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Short Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042281/
https://ncbi.nlm.nih.gov/pubmed/29996866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-1005-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars